Innate Pharma Management
Management criteria checks 4/4
Innate Pharma's CEO is Herve Brailly, appointed in Jan 1999, has a tenure of 25.33 years. directly owns 0.92% of the company’s shares, worth €1.78M. The average tenure of the management team and the board of directors is 4.2 years and 5.5 years respectively.
Key information
Herve Brailly
Chief executive officer
€100.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 25.3yrs |
| CEO ownership | 0.9% |
| Management average tenure | 4.2yrs |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
Innate Pharma S.A. (EPA:IPH) Annual Results: Here's What Analysts Are Forecasting For This Year
Mar 24
Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?
Dec 21Analysts' Revenue Estimates For Innate Pharma S.A. (EPA:IPH) Are Surging Higher
Sep 30Some Innate Pharma S.A. (EPA:IPH) Analysts Just Made A Major Cut To Next Year's Estimates
Sep 16Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?
Jun 09News Flash: Analysts Just Made A Massive Upgrade To Their Innate Pharma S.A. (EPA:IPH) Forecasts
Mar 30Rainbows and Unicorns: Innate Pharma S.A. (EPA:IPH) Analysts Just Became A Lot More Optimistic
Dec 18Does Innate Pharma (EPA:IPH) Have A Healthy Balance Sheet?
Sep 27Innate Pharma S.A. (EPA:IPH) Analysts Are Reducing Their Forecasts For This Year
Aug 04Industry Analysts Just Made A Dazzling Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts
May 12Industry Analysts Just Made A Captivating Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts
Apr 13Time To Worry? Analysts Just Downgraded Their Innate Pharma S.A. (EPA:IPH) Outlook
Mar 26Is Innate Pharma (EPA:IPH) Weighed On By Its Debt Load?
Nov 11Revenue Downgrade: Here's What Analysts Forecast For Innate Pharma S.A. (EPA:IPH)
May 13Is Innate Pharma (EPA:IPH) Using Debt Sensibly?
May 04A Look At Innate Pharma's (EPA:IPH) Share Price Returns
Feb 26Could The Innate Pharma S.A. (EPA:IPH) Ownership Structure Tell Us Something Useful?
Dec 24
If You Had Bought Innate Pharma's (EPA:IPH) Shares Five Years Ago You Would Be Down 67%
Nov 28CEO
Herve Brailly (62 yo)
25.3yrs
Tenure
€100,000
Compensation
Dr. Herve Brailly, Ph.D. Co-Founded Innate Pharma S.A in 1999 and served as its Chairman of Supervisory Board since December 31, 2016 until January 1, 2024 and serves as its Interim CEO and Chairman of the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 25.3yrs | €100.00k | 0.92% € 1.8m | |
| Executive VP | 9yrs | €599.92k | 0.24% € 468.0k | |
| Founder | no data | no data | no data | |
| Founder | 6.3yrs | no data | 0.26% € 506.7k | |
| Founder | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Senior VP & CFO | 3.1yrs | no data | 0.014% € 27.4k | |
| Executive VP | less than a year | no data | no data | |
| Executive VP | less than a year | no data | no data | |
| Vice President of Investor Relations & Communication | 1.3yrs | no data | 0.0039% € 7.7k | |
| Vice President of Compliance & Operations | 5.3yrs | no data | 0.077% € 150.0k |
4.2yrs
Average Tenure
56yo
Average Age
Experienced Management: IPH's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Strategic Advisory Board Member | 5.5yrs | no data | no data | |
| Member of Supervisory Board | no data | no data | no data | |
| Strategic Advisory Board Member | 5.5yrs | no data | no data | |
| Independent Member of Supervisory Board | 16.9yrs | €29.00k | 0.090% € 176.1k | |
| Independent Member of Supervisory Board | 6.4yrs | €29.00k | 0.000060% € 116.9 | |
| Independent Chairwoman of Supervisory Board | 14.9yrs | €42.00k | 0.031% € 60.5k | |
| Independent Vice Chairperson of the Supervisory Board | 4yrs | €60.00k | 0.0012% € 2.4k | |
| Chairman of Strategic Advisory Board | 5.5yrs | no data | no data | |
| Independent Member of Supervisory Board | 9.1yrs | €48.00k | 0.00082% € 1.6k | |
| Strategic Advisory Board Member | 5.5yrs | no data | no data | |
| Strategic Advisory Board Member | 5.5yrs | no data | no data | |
| Strategic Advisory Board Member | 5.5yrs | no data | no data |
5.5yrs
Average Tenure
62yo
Average Age
Experienced Board: IPH's board of directors are considered experienced (5.5 years average tenure).